title: Imaging, radiation oncology and randomised trials: time for a change?
abstract: We discuss the relevance of current trends in clinical trial conduct in light of the burgeoning need to underpin our practice with evidence, the contribution of novel imaging approaches to provide acceptable surrogate endpoints of effect and their place in the individualised medicine of the future.
authors.affiliation: Division of Radiation Oncology Centre for Molecular Imaging, University of Melbourne, Melbourne, Victoria, Australia. gillian.duchesne@petermac.org
authors.forename: Gillian M
authors.initials: GM
authors.lastname: Duchesne
authors.forename: Shih-Chang
authors.initials: SC
authors.lastname: Wang
authors.forename: Rodney J
authors.initials: RJ
authors.lastname: Hicks
mesh_terms: D003952:Diagnostic Imaging / Q000639:trends*; D019317:Evidence-Based Medicine / Q000639:trends*; D005544:Forecasting; D018787:Radiation Oncology / Q000639:trends*; D016032:Randomized Controlled Trials as Topic / Q000639:trends*